Skip to main content
. 2011 Feb 15;2011(2):CD005504. doi: 10.1002/14651858.CD005504.pub2

Comparison 2. Levodopa versus other dopamine agonists.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Change on IRLS 2 422 Mean Difference (IV, Random, 95% CI) 5.25 [2.10, 8.40]
2 Periodic limb movements per time in bed 1 78 Mean Difference (IV, Random, 95% CI) 3.80 [‐1.48, 9.08]
3 Total sleep time 1 22 Mean Difference (IV, Random, 95% CI) ‐76.0 [‐155.82, 3.82]
4 Number of dropouts due to adverse events 3 504 Odds Ratio (M‐H, Random, 95% CI) 0.59 [0.33, 1.04]
5 CGI‐Improvement 1 344 Mean Difference (IV, Random, 95% CI) 0.62 [0.37, 0.87]
6 Change in self rated quality of sleep 1 344 Mean Difference (IV, Random, 95% CI) 0.63 [‐0.09, 1.35]
7 Change in disease specific quality of life 1 314 Mean Difference (IV, Random, 95% CI) 5.54 [2.65, 8.43]
8 Number of patients experiencing adverse events 3 461 Odds Ratio (M‐H, Random, 95% CI) 0.35 [0.05, 2.30]